BofA Raises PT on Gilead Sciences (GILD) to $162 From $154 – Here’s Why

Gilead Sciences, Inc. (NASDAQ:GILD) is 1 of the champion aesculapian probe stocks to bargain according to hedge funds. On February 11, BofA lifted the terms people connected Gilead Sciences, Inc. (NASDAQ:GILD) to $162 from $154, maintaining a Buy standing connected the shares. The steadfast told investors successful a post-earnings enactment that it is assured successful 2026 maturation for the institution owed to coagulated fiscal Q4 dynamics, adding that it nary longer models Yeztugo cannibalization of Descovy income successful 2026.

The standing update came aft Gilead Sciences, Inc. (NASDAQ:GILD) announced its fiscal Q4 and afloat twelvemonth 2025 results connected February 10, stating that 2025 was a beardown twelvemonth for the institution overall, marked by the palmy motorboat of Yeztugo, which is the world’s archetypal twice-yearly HIV prevention therapy successful the country, and the continued maturation for Biktarvy and Descovy.

Gilead Sciences, Inc. (NASDAQ:GILD) further reported that the full fiscal Q4 revenues roseate 5% to $7.9 cardinal compared to the anterior twelvemonth period, driven chiefly by the accrued income of HIV and Liver Disease products and partially offset by little income of Veklury®.

Gilead Sciences, Inc. (NASDAQ:GILD) is simply a biotech institution that advances medicines to forestall and dainty superior diseases specified arsenic cancer, immunodeficiency microorganism (HIV), viral hepatitis, and COVID-19. Its portfolio of drugs focuses connected aesculapian areas with unmet needs, and includes AmBisome, Atripla, Biktarvy, Cayston, Complera, and others.

While we admit the imaginable of GILD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.